SCM

Stonepine Capital Management Portfolio holdings

AUM $102M
This Quarter Return
-7.67%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
Cap. Flow
-$28M
Cap. Flow %
-27.14%
Top 10 Hldgs %
76.67%
Holding
32
New
7
Increased
5
Reduced
14
Closed
6

Top Buys

1
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$7.55M
2
AMRN
Amarin Corp
AMRN
$4.68M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
$3.87M
4
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
$2.33M
5
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$2M

Top Sells

1
VNDA icon
Vanda Pharmaceuticals
VNDA
$18.9M
2
LGND icon
Ligand Pharmaceuticals
LGND
$13.7M
3
APEN
Apollo Endosurgery, Inc.
APEN
$3.68M
4
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
$3.44M
5
ALIM
Alimera Sciences, Inc.
ALIM
$2.09M

Sector Composition

1 Healthcare 96.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DMAC icon
26
DiaMedica Therapeutics
DMAC
$275M
$28K 0.03%
+13,705
New +$28K
MTNB icon
27
Matinas BioPharma
MTNB
$10.2M
– –
-668,615
Closed -$573K
VNDA icon
28
Vanda Pharmaceuticals
VNDA
$278M
– –
-1,341,943
Closed -$18.9M
MOTS
29
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
– –
-35,205
Closed -$107K
VIVE
30
DELISTED
VIVEVE MED INC
VIVE
– –
-3,403,402
Closed -$1.29M
SBBP
31
DELISTED
Strongbridge Biopharma plc.
SBBP
– –
-162,244
Closed -$508K
FOMX
32
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-651,211
Closed -$1.55M
1
2